Latest news
Apogee Therapeutics Positive Interim Results From Phase 1b Trial Of Zumilokibart (APG777) | Jan 06 Gorton School Lockdown (mvSdngPTwI) - MshaleMshale · Tue, 11 Aug 2026 06:04:47 GMTAbbVie to Acquire Apogee Therapeutics for $10.9 Billion; Apogee Reports Positive Phase 2 Zumilokibart Data and Q2 2026 Results - Quiver QuantitativeQuiver Quantitative · Mon, 10 Aug 2026 11:15:00 GMT